Should I stay or should I go? Coping with Cfius woes

Chinese buyers caught in a US regulatory quagmire can take their chances with smaller deals or hope a massive shake-up of Washington's dealings with Beijing brings a little clarity.
October 26, 2017

In the age of President Donald Trump, Chinese M&A dealmakers need no reminder that doing business in the United States will be a gruelling, soul-destroying and, perhaps, fruitless experience – especially when it comes to buying technology assets or companies that handle US citizens' data.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Related Articles

China's US M&A woes are only just warming up

The Trump administration is beginning to back up its beligerent words with action, and deals in the biotech and semiconductors sectors are at particular risk.
August 30, 2017